Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Periostat enters phase III trial for the treatment of rosacea

Aug. 21, 2002

Serono and Genentech sign marketing agreement for Raptiva, formerly Xanelim

Aug. 9, 2002

Inamed acquires rights to botulinum toxin type A

Aug. 8, 2002

Modex advances Allox through early-stage clinical testing

Aug. 7, 2002

Potential use of efalizumab in the treatment of T-cell-mediated diseases

Aug. 6, 2002

GRP promotes keratinocyte proliferation and wound healing in vitro and in vivo

Aug. 5, 2002

Access initiates OraDisc phase III trial, acquires rights to amlexanox

July 26, 2002

Karo Bio to outlicense KB-002611

July 25, 2002

Organogenesis negotiates return of Apligraf rights from Novartis

July 25, 2002

Celltech identifies new inhibitors of LFA-1/ICAM-1 interaction

July 17, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...